According to the research report, the global research antibodies market size is expected to touch USD 6.54 Billion by 2032, from USD 4 Billion in 2022, growing with a significant CAGR of 5.04% from 2023 to 2032.
The research antibodies report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global research antibodies in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global research antibodies market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global research antibodies during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2999
This study covers a detailed segmentation of the global research antibodies market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global research antibodies market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Cell Signalling Technology, Inc.
- Abcam Plc.
- PerkinElmer, Inc.
- Bio-Techne Corporation
- Proteintech Group, Inc.
- Santa Cruz Biotechnology Inc.
- Jackson ImmunoResearch Inc.
Market Segmentation
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
By Source
- Mouse
- Rabbit
- Goat
By Product
- Primary Antibodies
- Secondary Antibodies
By Technology
- Immunohistochemistry
- Immunoprecipitation
- Immunofluorescence
- Flow Cytometry
- Western Blotting
- ELISA
By Application
- Infectious Diseases
- Oncology
- Immunology
- Stem Cells
- Neurobiology
By End-User
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global research antibodies report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global research antibodies market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Research Antibodies Market
5.1. COVID-19 Landscape: Research Antibodies Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Research Antibodies Market, By Type
8.1. Research Antibodies Market, by Type, 2023-2032
8.1.1. Monoclonal Antibodies
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Polyclonal Antibodies
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Research Antibodies Market, By Source
9.1. Research Antibodies Market, by Source, 2023-2032
9.1.1. Mouse
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Rabbit
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Goat
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Research Antibodies Market, By Product
10.1. Research Antibodies Market, by Product, 2023-2032
10.1.1. Primary Antibodies
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Secondary Antibodies
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Research Antibodies Market, By Technology
11.1. Research Antibodies Market, by Technology, 2023-2032
11.1.1. Immunohistochemistry
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Immunoprecipitation
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Immunofluorescence
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Flow Cytometry
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Western Blotting
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. ELISA
11.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Research Antibodies Market, By Application
12.1. Research Antibodies Market, by Application, 2023-2032
12.1.1. Infectious Diseases
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Oncology
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Immunology
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Stem Cells
12.1.4.1. Market Revenue and Forecast (2020-2032)
12.1.5. Neurobiology
12.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Research Antibodies Market, By End-User
13.1. Research Antibodies Market, by End-User, 2023-2032
13.1.1. Academic & Research Institutes
13.1.1.1. Market Revenue and Forecast (2020-2032)
13.1.2. Contract Research Organizations
13.1.2.1. Market Revenue and Forecast (2020-2032)
13.1.3. Pharmaceutical & Biotechnology Companies
13.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 14. Global Research Antibodies Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type (2020-2032)
14.1.2. Market Revenue and Forecast, by Source (2020-2032)
14.1.3. Market Revenue and Forecast, by Product (2020-2032)
14.1.4. Market Revenue and Forecast, by Technology (2020-2032)
14.1.5. Market Revenue and Forecast, by Application (2020-2032)
14.1.6. Market Revenue and Forecast, by End-User (2020-2032)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Type (2020-2032)
14.1.7.2. Market Revenue and Forecast, by Source (2020-2032)
14.1.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.1.7.4. Market Revenue and Forecast, by Technology (2020-2032)
14.1.8. Market Revenue and Forecast, by Application (2020-2032)
14.1.8.1. Market Revenue and Forecast, by End-User (2020-2032)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type (2020-2032)
14.1.9.2. Market Revenue and Forecast, by Source (2020-2032)
14.1.9.3. Market Revenue and Forecast, by Product (2020-2032)
14.1.9.4. Market Revenue and Forecast, by Technology (2020-2032)
14.1.10. Market Revenue and Forecast, by Application (2020-2032)
14.1.11. Market Revenue and Forecast, by End-User (2020-2032)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type (2020-2032)
14.2.2. Market Revenue and Forecast, by Source (2020-2032)
14.2.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.4. Market Revenue and Forecast, by Technology (2020-2032)
14.2.5. Market Revenue and Forecast, by Application (2020-2032)
14.2.6. Market Revenue and Forecast, by End-User (2020-2032)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type (2020-2032)
14.2.8.2. Market Revenue and Forecast, by Source (2020-2032)
14.2.8.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.9. Market Revenue and Forecast, by Technology (2020-2032)
14.2.10. Market Revenue and Forecast, by Application (2020-2032)
14.2.10.1. Market Revenue and Forecast, by End-User (2020-2032)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Type (2020-2032)
14.2.11.2. Market Revenue and Forecast, by Source (2020-2032)
14.2.11.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.12. Market Revenue and Forecast, by Technology (2020-2032)
14.2.13. Market Revenue and Forecast, by Application (2020-2032)
14.2.14. Market Revenue and Forecast, by End-User (2020-2032)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Type (2020-2032)
14.2.15.2. Market Revenue and Forecast, by Source (2020-2032)
14.2.15.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.15.4. Market Revenue and Forecast, by Technology (2020-2032)
14.2.16. Market Revenue and Forecast, by Application (2020-2032)
14.2.16.1. Market Revenue and Forecast, by End-User (2020-2032)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Type (2020-2032)
14.2.17.2. Market Revenue and Forecast, by Source (2020-2032)
14.2.17.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.17.4. Market Revenue and Forecast, by Technology (2020-2032)
14.2.18. Market Revenue and Forecast, by Application (2020-2032)
14.2.18.1. Market Revenue and Forecast, by End-User (2020-2032)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type (2020-2032)
14.3.2. Market Revenue and Forecast, by Source (2020-2032)
14.3.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.4. Market Revenue and Forecast, by Technology (2020-2032)
14.3.5. Market Revenue and Forecast, by Application (2020-2032)
14.3.6. Market Revenue and Forecast, by End-User (2020-2032)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Type (2020-2032)
14.3.7.2. Market Revenue and Forecast, by Source (2020-2032)
14.3.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.7.4. Market Revenue and Forecast, by Technology (2020-2032)
14.3.8. Market Revenue and Forecast, by Application (2020-2032)
14.3.9. Market Revenue and Forecast, by End-User (2020-2032)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Type (2020-2032)
14.3.10.2. Market Revenue and Forecast, by Source (2020-2032)
14.3.10.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.10.4. Market Revenue and Forecast, by Technology (2020-2032)
14.3.11. Market Revenue and Forecast, by Application (2020-2032)
14.3.11.1. Market Revenue and Forecast, by End-User (2020-2032)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Type (2020-2032)
14.3.12.2. Market Revenue and Forecast, by Source (2020-2032)
14.3.12.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.12.4. Market Revenue and Forecast, by Technology (2020-2032)
14.3.12.5. Market Revenue and Forecast, by Application (2020-2032)
14.3.12.6. Market Revenue and Forecast, by End-User (2020-2032)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Type (2020-2032)
14.3.13.2. Market Revenue and Forecast, by Source (2020-2032)
14.3.13.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.13.4. Market Revenue and Forecast, by Technology (2020-2032)
14.3.13.5. Market Revenue and Forecast, by Application (2020-2032)
14.3.13.6. Market Revenue and Forecast, by End-User (2020-2032)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type (2020-2032)
14.4.2. Market Revenue and Forecast, by Source (2020-2032)
14.4.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.4. Market Revenue and Forecast, by Technology (2020-2032)
14.4.5. Market Revenue and Forecast, by Application (2020-2032)
14.4.6. Market Revenue and Forecast, by End-User (2020-2032)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Type (2020-2032)
14.4.7.2. Market Revenue and Forecast, by Source (2020-2032)
14.4.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.7.4. Market Revenue and Forecast, by Technology (2020-2032)
14.4.8. Market Revenue and Forecast, by Application (2020-2032)
14.4.9. Market Revenue and Forecast, by End-User (2020-2032)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Type (2020-2032)
14.4.10.2. Market Revenue and Forecast, by Source (2020-2032)
14.4.10.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.10.4. Market Revenue and Forecast, by Technology (2020-2032)
14.4.11. Market Revenue and Forecast, by Application (2020-2032)
14.4.12. Market Revenue and Forecast, by End-User (2020-2032)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Type (2020-2032)
14.4.13.2. Market Revenue and Forecast, by Source (2020-2032)
14.4.13.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.13.4. Market Revenue and Forecast, by Technology (2020-2032)
14.4.13.5. Market Revenue and Forecast, by Application (2020-2032)
14.4.13.6. Market Revenue and Forecast, by End-User (2020-2032)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Type (2020-2032)
14.4.14.2. Market Revenue and Forecast, by Source (2020-2032)
14.4.14.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.14.4. Market Revenue and Forecast, by Technology (2020-2032)
14.4.14.5. Market Revenue and Forecast, by Application (2020-2032)
14.4.14.6. Market Revenue and Forecast, by End-User (2020-2032)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type (2020-2032)
14.5.2. Market Revenue and Forecast, by Source (2020-2032)
14.5.3. Market Revenue and Forecast, by Product (2020-2032)
14.5.4. Market Revenue and Forecast, by Technology (2020-2032)
14.5.5. Market Revenue and Forecast, by Application (2020-2032)
14.5.6. Market Revenue and Forecast, by End-User (2020-2032)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Type (2020-2032)
14.5.7.2. Market Revenue and Forecast, by Source (2020-2032)
14.5.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.5.7.4. Market Revenue and Forecast, by Technology (2020-2032)
14.5.8. Market Revenue and Forecast, by Application (2020-2032)
14.5.8.1. Market Revenue and Forecast, by End-User (2020-2032)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type (2020-2032)
14.5.9.2. Market Revenue and Forecast, by Source (2020-2032)
14.5.9.3. Market Revenue and Forecast, by Product (2020-2032)
14.5.9.4. Market Revenue and Forecast, by Technology (2020-2032)
14.5.9.5. Market Revenue and Forecast, by Application (2020-2032)
14.5.9.6. Market Revenue and Forecast, by End-User (2020-2032)
Chapter 15. Company Profiles
15.1. Merck KGaA
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Thermo Fisher Scientific, Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Becton, Dickinson and Company
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Cell Signalling Technology, Inc.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Abcam Plc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. PerkinElmer, Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Bio-Techne Corporation
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Bio-Techne Corporation
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Proteintech Group, Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Santa Cruz Biotechnology Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments